Ultimate Woman
Natural health product licensed in Canada
- Licence holder
- System Biologie AG
- NPN or DIN-HM
- 80072302
- Status
- Active licence
- Licence date
- 26 August 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 7.5 microgrammes | Not calculated |
| Brassica oleracea var. italica Source : Sommité Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 3,600 milligramme | 120 milligramme | Not calculated |
| Zinc Source : Citrate de zinc | 7.5 milligramme | 7,500 µg |
| Manganèse Source : Citrate de manganèse (II) | 1 milligramme | 1,000 µg |
| 1,3,7-triméthylxanthine Source : Caféine | 3 milligramme | Not calculated |
| Lycopène tout trans Source : Solanum lycopersicum - fruit | 7.5 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 32:1 Dry plant equivalent : 1,920 milligramme Potency : 1 mg ÉAI Isoflavones | 60 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Potency : 1.3 mg Isoflavones | Not specified | Not calculated |
| Vaccinium angustifolium Source : Fruit Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 12,000 milligramme Potency : 30 milligramme Anthocyanins | 120 milligramme | Not calculated |
| Folate Source : L-5-methyltetrahydrofolate | 300 microgrammes | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Helps to form red blood cells. Helps in energy metabolism in the body. Helps to maintain immune function. Helps in the process of normal cell division. Helps in the development and maintenance of bones and teeth. Helps to maintain healthy skin. Helps in energy metabolism and tissue formation. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking blood thinners, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant, if you are taking antiplatelet medication or blood thinners, if you have gallstones or a bile duct obstruction, if you have stomach ulcers or excess stomach acid, or if you have an iron deficiency. Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRT) including thyroid hormone replacement therapy. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness. Consult a health care practitioner prior to use if you are breastfeeding. Folate supplementation can mask a vitamin B12 deficiency. If you are unsure whether you are taking enough vitamin B12, consult a health care practitioner prior to use. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
Source
Official Health Canada record, licence 80072302
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.